Le Lézard
Classified in: Health
Subjects: PDT, MAT

Edmedcare Introduces Elite Medication for Erectile Dysfunction and a Fast Discreet Online Doctor Consultation


NEW YORK, March 4, 2020 /PRNewswire/ -- Edmedcare.com is offering free, fast, online and discreet consultation for erectile dysfunction with a licensed MD from the privacy of the consumer's home. Once approved, a licensed pharmacy will deliver specially formulated ED medication containing NZT-V and NZT-C to the customer's doorstep.

"Edmedcare has compounded a unique formula that successfully addresses erectile dysfunction by taking Sildenafil 100mg (generic for Viagra) and Tadalafil 20mg (generic for Cialis) and tweaking them with our unique amino blend called NZT-V 112mg and NZT-C 24mg," says Michael Luchen, CEO of Edmedcare. "This treatment is the strongest available ED prescription medication on the market today."

NZT-V contains 112mg of active Sildenafil and 24mg of active Tadalafil. Also available as a Prescription is Generic Viagra "Sildenafil" 100mg and Generic Cialis "Tadalafil" 20mg based on past health history.

The ED medication addresses problems related to Erectile Dysfunction also known as "ED". Edmedcare's online system is HIPAA compliant and starts with a free, online consultation.

About ED Medication:

The ED medication is exclusively available at Edmedcare. NZT-V is an ED Treatment that is compounded by one of our licensed pharmacies which contains 112 mg of Active Generic Viagra "Sildenafil" that's 12 mg higher than any treatment pill available in the market today. The NZT-C contains 24mg Generic Cialis "Tadalafil" which is 4 mg more potent than other tablets. Its pharmacy also adds amino acids like B12 complex to enhance the Viagra and Cialis.

Edmedcare.com

888-9GetMed

Related Images

edmedcare-leader-in-erectile.jpg
Edmedcare - Leader in Erectile Dysfunction
Edmedcare offers a free and fast online consultation with a state- licensed prescriber for ED treatment.

Related Links

Leadership in Erectile Dysfunction Treatments

SOURCE EDmedcare


These press releases may also interest you

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...

at 17:31
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...



News published on and distributed by: